Log in to save to my catalogue

Effectiveness of treatment for 31 patients with seropositive autoimmune autonomic ganglionopathy in...

Effectiveness of treatment for 31 patients with seropositive autoimmune autonomic ganglionopathy in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_131bad51a9ff422e9cc0f14c6ae01f61

Effectiveness of treatment for 31 patients with seropositive autoimmune autonomic ganglionopathy in Japan

About this item

Full title

Effectiveness of treatment for 31 patients with seropositive autoimmune autonomic ganglionopathy in Japan

Publisher

London, England: SAGE Publications

Journal title

Therapeutic advances in neurological disorders, 2022, Vol.15, p.17562864221110048-17562864221110048

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Background:
Autoimmune autonomic ganglionopathy (AAG) is characterized by serum autoantibodies against the ganglionic acetylcholine receptor (gAChR). Immunomodulatory treatments may alleviate AAG symptoms, but the most appropriate treatment strategy is unclear.
Objective:
This study aimed to confirm the effectiveness of treatments, particu...

Alternative Titles

Full title

Effectiveness of treatment for 31 patients with seropositive autoimmune autonomic ganglionopathy in Japan

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_131bad51a9ff422e9cc0f14c6ae01f61

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_131bad51a9ff422e9cc0f14c6ae01f61

Other Identifiers

ISSN

1756-2864,1756-2856

E-ISSN

1756-2864

DOI

10.1177/17562864221110048

How to access this item